PerkinElmer Executive and Leadership Team

Michael Stubblefield, the Chief Executive Officer at PerkinElmer, directs the overarching corporate strategy and long-term vision for the organization. Stubblefield manages the integration of diagnostic and life science solutions across global markets, ensuring alignment with the needs of researchers and clinicians. By overseeing the executive leadership team, the Chief Executive Officer drives operational excellence and maintains the company's competitive position in the applied markets. Michael Stubblefield prioritizes the expansion of the product portfolio to address critical scientific challenges. This leadership role involves constant engagement with the Board to refine business objectives and maximize shareholder value. Through the implementation of rigorous performance metrics, Stubblefield ensures that all departments contribute to the broader mission of improving health outcomes. The Chief Executive Officer maintains a focus on sustainable growth, guiding the company through complex regulatory environments while fostering a culture of innovation and scientific integrity across all international operations.

Michael Battles, the Chief Financial Officer at PerkinElmer, manages the financial health and fiscal strategy of the enterprise. Battles oversees capital allocation, financial reporting, and investor relations to ensure the company meets its growth targets. By directing the financial planning and analysis teams, the Chief Financial Officer provides the data-driven insights necessary for strategic decision-making across the diagnostics and life sciences divisions. Michael Battles monitors global market trends to mitigate financial risks and optimize resource distribution. This role requires close collaboration with the executive team to align budgetary priorities with the long-term goals of the organization. Through the management of complex financial structures, Battles supports the company's ability to invest in emerging technologies and research initiatives. The Chief Financial Officer maintains strict compliance with international accounting standards, ensuring transparency and stability for stakeholders while driving the financial performance required to sustain the company's leadership in the healthcare sector.

Jean-Pierre Ferrando, the Interim Chief Financial Officer at PerkinElmer, executes the immediate financial operations and maintains fiscal continuity for the organization. Ferrando directs the accounting and treasury functions, ensuring that all financial processes support the ongoing requirements of the diagnostics and life sciences business units. By overseeing the daily cash flow and budgetary controls, the Interim Chief Financial Officer provides the stability needed for uninterrupted operations. Jean-Pierre Ferrando collaborates with the executive leadership to manage short-term financial objectives while preparing for long-term strategic shifts. This role involves the rigorous assessment of operational costs and the optimization of internal financial systems to improve efficiency. Through the management of financial reporting cycles, Ferrando ensures that the company remains aligned with its fiscal commitments. The Interim Chief Financial Officer supports the broader organizational goals by maintaining precise financial oversight and facilitating the seamless execution of corporate initiatives across all global business segments.

Jeff Schroeder, the President, Strategic Accounts at PerkinElmer, directs the management and expansion of key client relationships within the diagnostics and life sciences sectors. Schroeder oversees the development of long-term partnerships with major research institutions and healthcare providers to ensure the company's solutions meet their most critical needs. By managing the strategic accounts team, the President, Strategic Accounts drives revenue growth through the delivery of tailored service models and high-impact product integrations. Jeff Schroeder collaborates with the executive leadership to identify new market opportunities and strengthen the company's presence in the applied markets. This role involves the negotiation of complex contracts and the alignment of service delivery with the specific requirements of large-scale clients. Through the implementation of account-based strategies, Schroeder ensures that the company maintains its status as a preferred partner for scientific innovation. The President, Strategic Accounts focuses on maximizing client satisfaction and driving sustainable growth across all major global territories.

Richard Begley, the President, Emerging Technologies at PerkinElmer, directs the research and development of next-generation solutions for the diagnostics and life sciences markets. Begley oversees the identification and incubation of innovative technologies that address the most critical challenges in science and healthcare. By managing the emerging technologies division, the President, Emerging Technologies drives the transition of experimental concepts into scalable commercial products. Richard Begley collaborates with the executive team to align the R&D pipeline with the company's long-term strategic goals and market trends. This role involves the oversight of technical teams and the management of partnerships with academic and research institutions to foster scientific breakthroughs. Through the exploration of new technological frontiers, Begley ensures that the company remains at the forefront of industry innovation. The President, Emerging Technologies maintains a focus on accelerating the development cycle, enabling the organization to provide cutting-edge tools to researchers and clinicians worldwide.

Kristen Norris, the Chief Human Resources Officer at PerkinElmer, directs the global talent strategy and organizational development initiatives. Norris oversees recruitment, employee engagement, and leadership training to ensure the company attracts and retains top-tier scientific and technical talent. By managing the human capital framework, the Chief Human Resources Officer aligns workforce capabilities with the evolving demands of the diagnostics and life sciences markets. Kristen Norris implements performance management systems that foster a culture of innovation and accountability. This role involves working with the executive team to design compensation structures and benefits programs that support the company's competitive positioning. Through the development of inclusive workplace policies, Norris drives employee retention and professional growth across all international regions. The Chief Human Resources Officer ensures that the organizational structure remains agile, enabling the company to respond effectively to the complex challenges faced by researchers and clinicians in the healthcare industry.

Alexey Sosnovskiy, the Senior Vice President, Customer Enablement and Chief of Staff at PerkinElmer, directs the strategic alignment of customer-facing initiatives and internal executive operations. Sosnovskiy oversees the integration of support services that enable researchers and clinicians to utilize the company's diagnostic solutions effectively. By managing the Chief of Staff functions, the Senior Vice President ensures that the executive team remains focused on high-priority business objectives and cross-functional collaboration. Alexey Sosnovskiy drives the implementation of customer enablement programs that enhance the user experience across the life sciences and applied markets. This role involves coordinating complex projects that span multiple departments to ensure operational efficiency and strategic consistency. Through the optimization of customer support workflows, Sosnovskiy supports the company's mission to address critical scientific challenges. The Senior Vice President maintains a focus on scaling these enablement efforts globally, ensuring that the organization delivers consistent value to its diverse client base.

Walter Discenza, the Chief Information Officer & Director, Worldwide IT at PerkinElmer, directs the global technology infrastructure and digital transformation strategy. Discenza oversees the implementation of secure data systems that support the company's research, diagnostics, and life sciences operations. By managing the worldwide IT architecture, the Chief Information Officer & Director, Worldwide IT ensures that all digital platforms remain scalable and resilient against emerging cyber threats. Walter Discenza coordinates with the executive team to integrate advanced analytics and cloud solutions that accelerate scientific discovery. This role involves the oversight of global IT operations, ensuring that the company's technological capabilities align with the needs of clinicians and researchers. Through the modernization of internal systems, Discenza drives operational efficiency and data integrity across all international business units. The Chief Information Officer & Director, Worldwide IT maintains a focus on leveraging technology to enhance the company's market position and support the delivery of critical healthcare solutions.